Dr Yvonne Freund Levi, MD PhD - NVS Karolinska Institutet - Associate Professor

Dr Yvonne Freund Levi

MD PhD

NVS Karolinska Institutet

Associate Professor

Stockholm | Sweden

Main Specialties: Addiction Psychiatry, Child & Adolescent Psychiatry, Clinical & Laboratory Immunology, Clinical Neurophysiology, Forensic Psychiatry, Geriatric Medicine, Geriatric Psychiatry, Neurology, Pain Medicine, Psychiatry, Public Health, Sleep Medicine, Sports Medicine

Additional Specialties: Geriatrics Psychiatry

ORCID logohttps://orcid.org/0000-0001-6863-6679

Dr Yvonne Freund Levi, MD PhD - NVS Karolinska Institutet - Associate Professor

Dr Yvonne Freund Levi

MD PhD

Education

Jan 2004
Karolinska Institutet
MD PhD Ass Professor
Institution of Neurobilogy care and Sciences
Jan 1994
Specialist psychiatry
Jan 1987
Lisc Psychotherapist Psychodynamic
Specialist Geriatrics
Psychotherapist Cognitive behavioural Adv level

Experience

Oct 2018
Örebro Universitet Institutionen för Medicinska Vetenskaper
Senior lecturer ( lektor)
Department of Medical Sciences
Oct 2018
Universitetssjukhuset Orebro
Senior lecturer ( överläkare)
Department of Psychiatry
Jan 1995
Karolinska Universitetssjukhuset
Senior MD
Dep of Geriatrics
Jan 1987
Sankt Görans SjukhusDep Psyciatry
Senior MD
Psychiatry
Karolinska Institutet

Department of Neurobiology, Care Sciences and Society

Publications

82Publications

942Reads

2Profile Views

685PubMed Central Citations

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Authors:
Niklas Mattsson Colin Groot Willemijn J Jansen Susan M Landau Victor L Villemagne Sebastiaan Engelborghs Mark M Mintun Alberto Lleo José Luis Molinuevo William J Jagust Giovanni B Frisoni Adrian Ivanoiu Gaël Chételat Catarina Resende de Oliveira Karen M Rodrigue Johannes Kornhuber Anders Wallin Aleksandra Klimkowicz-Mrowiec Ramesh Kandimalla Julius Popp Pauline P Aalten Dag Aarsland Daniel Alcolea Ina S Almdahl Inês Baldeiras Mark A van Buchem Enrica Cavedo Kewei Chen Ann D Cohen Stefan Förster Juan Fortea Kristian S Frederiksen Yvonne Freund-Levi Kiran Dip Gill Olymbia Gkatzima Timo Grimmer Harald Hampel Sanna-Kaisa Herukka Peter Johannsen Koen van Laere Mony J de Leon Wolfgang Maier Jan Marcusson Olga Meulenbroek Hanne M Møllergård John C Morris Barbara Mroczko Arto Nordlund Sudesh Prabhakar Oliver Peters Lorena Rami Eloy Rodríguez-Rodríguez Catherine M Roe Eckart Rüther Isabel Santana Johannes Schröder Sang W Seo Hilkka Soininen Luiza Spiru Erik Stomrud Hanne Struyfs Charlotte E Teunissen Frans R J Verhey Stephanie J B Vos Linda J C van Waalwijk van Doorn Gunhild Waldemar Åsa K Wallin Jens Wiltfang Rik Vandenberghe David J Brooks Tormod Fladby Christopher C Rowe Alexander Drzezga Marcel M Verbeek Marie Sarazin David A Wolk Adam S Fleisher William E Klunk Duk L Na Pascual Sánchez-Juan Dong Young Lee Agneta Nordberg Magda Tsolaki Vincent Camus Juha O Rinne Anne M Fagan Henrik Zetterberg Kaj Blennow Gil D Rabinovici Oskar Hansson Bart N M van Berckel Wiesje M van der Flier Philip Scheltens Pieter Jelle Visser Rik Ossenkoppele

Alzheimers Dement 2018 07 28;14(7):913-924. Epub 2018 Mar 28.

Clinical Memory Research Unit, Clinical Sciences Malmö, Lund University, Lund, Sweden; Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands; Department of Radiology and Nuclear Medicine, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2018.02.009DOI Listing
July 2018
59 Reads
1 Citation
12.410 Impact Factor

Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study.

J Alzheimers Dis 2014 ;42(3):823-31

Division of Oxidative Stress and Inflammation, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden and Chaire d'Excellence Program, Department of Biochemistry, Molecular Biology and Nutrition, Universite d'Auvergne, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-132042DOI Listing
August 2015
48 Reads
9 Citations
4.151 Impact Factor

Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index.

Curr Alzheimer Res 2015 ;12(1):69-79

University of Eastern Finland, Institute of Clinical Medicine/Neurology, P.O.Box 1627, 70211 Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1567205012666141218123829DOI Listing
August 2015
66 Reads
4 Citations
3.890 Impact Factor

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Authors:
Willemijn J Jansen Rik Ossenkoppele Dirk L Knol Betty M Tijms Philip Scheltens Frans R J Verhey Pieter Jelle Visser Pauline Aalten Dag Aarsland Daniel Alcolea Myriam Alexander Ina S Almdahl Steven E Arnold Inês Baldeiras Henryk Barthel Bart N M van Berckel Kristen Bibeau Kaj Blennow David J Brooks Mark A van Buchem Vincent Camus Enrica Cavedo Kewei Chen Gael Chetelat Ann D Cohen Alexander Drzezga Sebastiaan Engelborghs Anne M Fagan Tormod Fladby Adam S Fleisher Wiesje M van der Flier Lisa Ford Stefan Förster Juan Fortea Nadia Foskett Kristian S Frederiksen Yvonne Freund-Levi Giovanni B Frisoni Lutz Froelich Tomasz Gabryelewicz Kiran Dip Gill Olymbia Gkatzima Estrella Gómez-Tortosa Mark Forrest Gordon Timo Grimmer Harald Hampel Lucrezia Hausner Sabine Hellwig Sanna-Kaisa Herukka Helmut Hildebrandt Lianna Ishihara Adrian Ivanoiu William J Jagust Peter Johannsen Ramesh Kandimalla Elisabeth Kapaki Aleksandra Klimkowicz-Mrowiec William E Klunk Sebastian Köhler Norman Koglin Johannes Kornhuber Milica G Kramberger Koen Van Laere Susan M Landau Dong Young Lee Mony de Leon Viviana Lisetti Alberto Lleó Karine Madsen Wolfgang Maier Jan Marcusson Niklas Mattsson Alexandre de Mendonça Olga Meulenbroek Philipp T Meyer Mark A Mintun Vincent Mok José Luis Molinuevo Hanne M Møllergård John C Morris Barbara Mroczko Stefan Van der Mussele Duk L Na Andrew Newberg Agneta Nordberg Arto Nordlund Gerald P Novak George P Paraskevas Lucilla Parnetti Gayan Perera Oliver Peters Julius Popp Sudesh Prabhakar Gil D Rabinovici Inez H G B Ramakers Lorena Rami Catarina Resende de Oliveira Juha O Rinne Karen M Rodrigue Eloy Rodríguez-Rodríguez Catherine M Roe Uros Rot Christopher C Rowe Eckart Rüther Osama Sabri Páscual Sanchez-Juan Isabel Santana Marie Sarazin Johannes Schröder Christin Schütte Sang W Seo Femke Soetewey Hilkka Soininen Luiza Spiru Hanne Struyfs Charlotte E Teunissen Magda Tsolaki Rik Vandenberghe Marcel M Verbeek Victor L Villemagne Stephanie J B Vos Linda J C van Waalwijk van Doorn Gunhild Waldemar Anders Wallin Åsa K Wallin Jens Wiltfang David A Wolk Marzena Zboch Henrik Zetterberg

JAMA 2015 May;313(19):1924-38

Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden87UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2015.4668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486209PMC
May 2015
131 Reads
164 Citations
35.290 Impact Factor

Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.

Dement Geriatr Cogn Disord 2014 25;38(3-4):234-44. Epub 2014 Jun 25.

Department of Neurobiology, Caring Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362204DOI Listing
May 2015
2 Reads
2 Citations
3.550 Impact Factor

Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study.

J Lipid Res 2015 Mar 23;56(3):674-81. Epub 2015 Jan 23.

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, SE-141 57, Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.P055418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340314PMC
March 2015
30 Reads
15 Citations
4.421 Impact Factor

Response to Bogaiksy's letter to the editor.

Am J Geriatr Psychiatry 2014 Sep 2;22(9):951. Epub 2014 Jun 2.

Department of Geriatric Medicine, Karolinska University Hospital, Stockhold, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2014.05.010DOI Listing
September 2014
3 Reads
4.240 Impact Factor

Neuropsychiatric symptoms in dementia-a role for neuroinflammation?

Brain Res Bull 2014 Sep 16;108:88-93. Epub 2014 Sep 16.

Department of Neurobiology, Care Sciences & Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden; Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainresbull.2014.09.003DOI Listing
September 2014
5 Reads
1 Citation
2.720 Impact Factor

Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.

Dement Geriatr Cogn Dis Extra 2014 May 27;4(2):335-43. Epub 2014 Aug 27.

Division of Clinical Geriatrics, Karolinska University Hospital Huddinge, Stockholm, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000363500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176467PMC
May 2014
5 Reads
2 Citations

Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.

Am J Geriatr Psychiatry 2014 Apr 10;22(4):341-8. Epub 2013 Sep 10.

Division of Clinical Geriatrics, Department of Neurobiology, Caring Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden; Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2013.05.005DOI Listing
April 2014
2 Reads
7 Citations
4.240 Impact Factor

Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study.

J Alzheimers Dis 2013 ;36(1):1-6

Department of NVS, Section of Clinical Nutrition, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-121828DOI Listing
December 2013
17 Reads
3 Citations
4.151 Impact Factor

Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers.

J Alzheimers Dis 2013 ;35(4):697-713

Division of Neurodegeneration, Department of Neurobiology, Care Sciences & Society, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-130131DOI Listing
December 2013
15 Reads
35 Citations
4.151 Impact Factor

Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid.

Curr Opin Clin Nutr Metab Care 2012 Mar;15(2):134-43

Division of Neurodegeneration, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCO.0b013e32835017ccDOI Listing
March 2012
1 Read
6 Citations
3.990 Impact Factor

Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study.

J Lipid Res 2010 May 24;51(5):1179-85. Epub 2009 Nov 24.

Department of Medicine, Caring Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M002667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853444PMC
May 2010
10 Reads
12 Citations
4.421 Impact Factor

Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.

Eur J Nucl Med Mol Imaging 2009 Nov 5;36(11):1859-63. Epub 2009 Jun 5.

AstraZeneca R&D, Neuroscience Therapy Area, 151 85 Södertälje, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-009-1182-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764092PMC
November 2009
4 Reads
14 Citations
5.383 Impact Factor

Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.

Dement Geriatr Cogn Disord 2009 12;27(5):481-90. Epub 2009 May 12.

Department NVS, Division of Clinical Geriatrics, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000218081DOI Listing
August 2009
12 Reads
21 Citations
3.550 Impact Factor

Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.

J Am Geriatr Soc 2009 Jan 20;57(1):11-7. Epub 2008 Nov 20.

Department of Neurobiology, Karolinska Institutet, Karolinska University, Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1532-5415.2008.02055.xDOI Listing
January 2009
15 Reads
11 Citations
4.572 Impact Factor

Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study.

Am J Clin Nutr 2008 Jun;87(6):1616-22

Department of Medicine and the Division of Clinical Nutrition and Metabolism Research, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcn/87.6.1616DOI Listing
June 2008
16 Reads
32 Citations
6.770 Impact Factor

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

Int J Geriatr Psychiatry 2008 Feb;23(2):161-9

Department of NVS, Section of Clinical Geriatrics, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gps.1857DOI Listing
February 2008
31 Reads
24 Citations
2.870 Impact Factor

[Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited].

Lakartidningen 2007 Oct 31-Nov 6;104(44):3268-71

Hematologiskt centrum och institutionen för medicin, Karolinska institutet och Karolinska Universitetssjukhuset Huddinge.

View Article

Download full-text PDF

Source
December 2007
3 Reads

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Arch Neurol 2006 Oct;63(10):1402-8

Department of Neurobiology, Caring Sciences and Society, Section of Clinical Geriatrics, Karolinska University Hospital Huddinge, Stockholm.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.63.10.1402DOI Listing
October 2006
59 Reads
126 Citations
7.420 Impact Factor

[Administration of symptom-relieving drugs in Alzheimer disease is beneficial].

Lakartidningen 2006 Feb 8-14;103(6):369-71

Geriatriska kliniken, Karolinska Universitetssjukhuset, Huddinge.

View Article

Download full-text PDF

Source
March 2006
4 Reads
1 Citation

Top co-authors

Tommy Cederholm
Tommy Cederholm

Clinical Nutrition and Metabolism

13
Jan Palmblad
Jan Palmblad

Karolinska Institutet

13
Inger Vedin
Inger Vedin

Karolinska Institutet

12
Hans Basun
Hans Basun

Karolinska Institutet

11
Erik Hjorth
Erik Hjorth

Karolinska Institutet

10
Pieter Jelle Visser
Pieter Jelle Visser

Maastricht University

8
Magda Tsolaki
Magda Tsolaki

Aristotle University of Thessaloniki

7